See also this year's filing and all EDGAR filings for this company.
PDF Report 0001514946_2019_AXIM_BIOTECHNOLOGIES_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001514946')"} |
Graph
Absolute values for 0001514946, AXIM BIOTECHNOLOGIES INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,022,529 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 53,692 |
| 2 | PropertyPlantAndEquipmentNet | 5,593 |
| 3 | remainder_Assets | 7,440 |
| 4 | LiabilitiesCurrent | 3,323,866 |
| 5 | LiabilitiesNoncurrent | 4,847,207 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 8,511 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,163,715 |
| 9 | ResearchAndDevelopmentExpense | 2,056,175 |
| 10 | remainder_Expenses | 3,356 |
| 11 | remainder_Revenues | 195,614 |
| 12 | remainder_NetIncome | -1,718,503 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,089,254 |
| 1 | Liabilities | 8,171,073 |
| 2 | Expenses | 5,231,757 |
| 3 | Revenues | 195,614 |
| 4 | StockholdersEquity | -6,081,819 |
| 5 | NetIncome | -6,754,646 |
| 6 | ComprehensiveNetIncome | -6,754,646 |
| 7 | BaseVar | 8,703,100 |
| 8 | EconomicCapitalRatio | -3.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
